Specialty Active Pharmaceutical Ingredients Market in Good Shape in 2030; COVID-19 to Affect Future Growth Trajectory
A recent market study published by Future Market Insights
(FMI) on the Specialty Active Pharmaceutical Ingredients (API) market offers
global industry analysis for 2015-2019 & opportunity assessment for
2020-2030. The report consists of a comprehensive assessment of the most
important market dynamics. On conducting thorough research on the historical as
well as current growth parameters of the market, growth prospects of the market
are obtained with maximum precision. The report features unique and salient
factors that may make a huge impact on the development of the market during the
forecast period. It can help market players modify their manufacturing and marketing
strategies to envisage maximum growth in the market in the coming years. The
report provides detailed information about the current and future growth
prospects of the market in the most comprehensive way for better understanding
of readers.
Request a sample-
Key Segments of Specialty Active
Pharmaceutical Ingredients (API) Market
FMI’s study on the market offers
information divided into four important segments— product type, technology,
consumption, and region. This report offers comprehensive data and information
about the important market dynamics and growth parameters associated with these
categories.
Product Type
Consumption
Region
·
Small Molecules API
o
Controlled Substances API
o
HPAPI
·
Peptides API
·
Carbohydrate Drugs API
·
Steroidal Drugs API
·
In-house
·
Outsourced
·
North America
·
Latin America
·
Europe
·
East Asia
·
South Asia
·
Oceania
·
Middle East and Africa
Chapter 1 – Executive Summary
The report commences with the executive
summary of the specialty active pharmaceutical ingredients (API) market report,
which includes the snapshot of key findings and statistics. It also includes
the market value (US$ million) estimates of the leading segments as along with
the key trends impacting the market.
Chapter 2 – Market Overview
Readers can find detailed taxonomy and
product definition of the specialty active pharmaceutical ingredients (API)
market in this chapter, which help readers understand basic information about
specialty active pharmaceutical ingredients (API).
Chapter 3 – Key Market Trends
This section highlights the key trends
impacting the API market, which will help readers understand the current trends
and their impact on market growth.
Chapter 5 – Global Specialty Active
Pharmaceutical Ingredients (API) Market Value (US$) Analysis 2015-2019 and
Forecast 2020-2030
This section explains the global market
value analysis and forecast for the API market during the forecast period.
Along with the historical market and opportunity analysis of the future.
Readers can also find the absolute $ opportunity for the current year (2020),
and an incremental $ opportunity for the forecast period (2020–2030).
Chapter 7 – Market Background
This chapter explains the macroeconomic
factors that are expected to influence the growth of the specialty active
pharmaceutical ingredients (API) market during the forecast period. It also
highlights the major forecast factors that will shape market growth. This
section also apprises about value chain analysis of the market. Besides, it
gives key dynamics of the market, which include the drivers, restraints, and
opportunity analysis.
The chapter is also expected to enable
readers to understand the factors that are propelling the growth of the
specialty active pharmaceutical ingredients (API) market, as well as those
likely to hamper the growth of the market. The opportunity analysis for the
specialty active pharmaceutical ingredients (API) will help readers understand
the market opportunities, based on which they can plan their strategies.
In addition this section does provide the
current and expected impact of COVID-19 on the market.
Chapter 8 – Global Specialty Active
Pharmaceutical Ingredients (API) Market Analysis (2015-2019) & Opportunity
Assessment (2020-2030), By Product Type
Based on product type, the market is
segmented into small molecules, peptides, carbohydrate drugs, and steroidal
drugs. In this chapter, readers can find detailed analysis of the market by
different product type of specialty active pharmaceutical ingredients (API) and
their growth over the forecast period.
Ask An Analyst-
Chapter 09 – Global Specialty Active
Pharmaceutical Ingredients (API) Market Analysis 2015-2019 & Opportunity
Assessment, 2020-2030, By Consumption
Based on consumption, the market spans
in-house and out sourced. In this chapter, readers can find information on
market attractive analysis based on consumption.
Chapter 11 – Global Specialty Active
Pharmaceutical Ingredients (API) Market Analysis 2015-2019 & Opportunity
Assessment 2020-2030, By Region
This chapter explains how the market will
grow across various geographic regions such as North America, Latin America,
Europe, East Asia, South Asia, Oceania, and the Middle East & Africa (MEA).
Chapter 12 – North America Specialty Active
Pharmaceutical Ingredients (API) Market Analysis 2015-2019 & Opportunity
Assessment 2020-2030
This chapter includes a detailed analysis
of the growth of North America’s specialty active pharmaceutical ingredients
(API) market along with the country-wise assessment including the U.S. and
Canada. Readers can also find key takeaways of this region, and market growth
based on product type, consumption, and country of Specialty Active
Pharmaceutical Ingredients (API) in the North American region.
Chapter 13 – Latin America Specialty Active
Pharmaceutical Ingredients (API) Market Analysis 2015-2019 & Opportunity
Assessment 2020-2030
This chapter includes the growth prospects
of the specialty active pharmaceutical ingredients (API) market in leading
countries such as Brazil, Mexico, and the rest of Latin America. Readers can
find thorough information about the growth parameters of the Latin America’s
market during 2020-2030.
Chapter 14 –Europe Specialty Active
Pharmaceutical Ingredients (API) Market Analysis 2015-2019 & Opportunity
Assessment 2020-2030
Important growth prospects of the market
based on product type, consumption, and country in several European countries
such as the U.K., Germany, France, Italy, Spain, Russia, BENELUX, and Rest of
Europe are included in this chapter.
Chapter 15 – East Asia Specialty Active
Pharmaceutical Ingredients (API) Market Analysis 2015-2019 and Forecast
2020-2030
Detailed information about factors such as
incremental opportunity, Y-O-Y growth, and regional trends that are impacting
the growth of East Asia’s market are included in this chapter. It also includes
the growth prospects of the specialty active pharmaceutical ingredients (API)
market in leading East Asian countries such as China, Japan, and South Korea.
Chapter 16– South Asia Specialty Active
Pharmaceutical Ingredients (API) Market Analysis 2015-2019 and Forecast
2020-2030
India, Indonesia, Malaysia, Thailand, and
the rest of South Asia are the leading countries/regions in South Asia that are
the prime subjects of assessment to obtain the growth prospects of South Asia’s
market. In this chapter, readers can find thorough information about the growth
parameters of the South Asia’s specialty active pharmaceutical ingredients
(API) market by 2030.
Chapter 17 – Oceania Specialty Active
Pharmaceutical Ingredients (API) Market Analysis 2014–2018 and Forecast
2020–2030
This chapter consists of important
parameters that have a huge impact on the growth of the market in Oceania,
based on market segmentation, during the forecast period. It also provides an
overview of the drivers, restraints, and trends in the Oceania’s specialty
active pharmaceutical ingredients (API) market.
Chapter 18 – MEA Specialty Active
Pharmaceutical Ingredients (API) Market Analysis 2015-2019 & Opportunity
Assessment 2020-2030
This chapter provides information on how
the market will grow in the major countries in MEA region, such as GCC
Countries, South Africa, Northern Africa, Turkey and Rest of MEA during
2020-2030.
Chapter 19 – Market Structure Analysis
This chapter covers the market analysis of
competitors based on revenue tiers, single point view of portfolio across
industry segments, and their relative market position.
Chapter 20 – Competition Analysis
In this chapter, readers can find a
comprehensive list of all the leading stakeholders in the specialty active
pharmaceutical ingredients (API) market, along with detailed information about
each company, including company overview, revenue shares, strategic overview,
and recent company developments. Players featured in the market report include
Corden Pharma International GmbH, Pepscan Holding NV, Provence Technologies
Group, BCN Peptides S.A., Senn Chemicals AG., Santaris Pharma A/S, Sanofi and
Pfizer Inc. among others.
Chapter 21– Assumptions and Acronyms Used
This chapter includes a list of acronyms
and assumptions that provide a base to the information and statistics included
in the report.
Chapter 22 – Research Methodology
This chapter helps readers understand the
research methodology followed to obtain various conclusions, important
qualitative information, and quantitative information about the specialty
active pharmaceutical ingredients (API) market.
Comments
Post a Comment